Healthcare Triangle, Inc.
HCTI
$2.32
$0.052.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 43.33% | 44.59% | 19.24% | -9.86% | -68.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.33% | 44.59% | 19.24% | -9.86% | -68.98% |
| Cost of Revenue | 39.14% | 69.78% | 46.88% | 9.05% | -65.03% |
| Gross Profit | 75.00% | -14.40% | -44.99% | -67.55% | -83.27% |
| SG&A Expenses | 193.23% | 125.16% | 17.13% | -23.89% | -28.71% |
| Depreciation & Amortization | 220.23% | -81.63% | -- | -97.76% | 36.25% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 182.07% | 69.83% | 12.72% | -12.37% | -59.98% |
| Operating Income | -792.17% | -122.02% | 1.38% | 18.39% | -245.19% |
| Income Before Tax | -235.04% | -52.85% | 9.34% | 8.70% | 19.62% |
| Income Tax Expenses | -- | -- | -- | -- | -42.86% |
| Earnings from Continuing Operations | -234.05% | -52.60% | 9.40% | 8.70% | 19.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -234.05% | -52.60% | 9.40% | 8.70% | 19.71% |
| EBIT | -792.17% | -122.02% | 1.38% | 18.39% | -245.19% |
| EBITDA | -1,282.52% | -206.80% | -11.12% | -17.76% | -105.32% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |